Pulling SEC filings + quote and writing the call…

Finward Bancorp
Next earnings Jul 27, 2026 · consensus $0.62 EPS, $19.3M rev
Last earnings -1.5% on 2026-04-28
Below-book small-cap thrift with a recovering regulatory profile but weak, shrinking earnings — a cheap-on-assets, dear-on-earnings hold.
Diluted EPS $1.88 · FY2025
Middling fundamentals and a rich price (~61% above fair value) leave little margin of safety — a wait-and-see.
Finward is the holding company for Peoples Bank, a ~$2.0B-asset Indiana thrift whose earnings power has deteriorated: FY2025 net income of $8.09M fell 33.3% YoY and diluted EPS of $1.88 dropped 33.8%, extending a choppy, downward multi-year path ($15.0M in 2021 and $15.1M in 2022, then $8.38M, $12.1M, and back to $8.09M). Management's own MD&A pegs FY2025 ROA at 0.39% and ROE at 5.10% (our XBRL-derived ROE is 4.6%) — sub-par returns for a bank, and the reason the stock can trade below book without being a bargain. As a spread lender, the Bank's fate hinges on net interest margin, which MD&A calls 'the clearest indicator' of core earnings; interest-earning assets actually shrank 1.4% in 2025, so there is little organic engine driving earnings back up.
The valuation cuts both ways. At $36.80 the P/E of 19.6 looks rich for a small thrift, but that multiple sits on depressed earnings — normalized against 2024's $12.1M the multiple would be far lower. More telling is price-to-book: against MD&A's stated book value of $40.37/share, the stock trades at roughly 0.91x book, a discount that offers downside cushion. Equity grew 15.4% to $175M and retained earnings rose 4.7%, so the capital base is building even as the income statement stumbles. That is the classic setup for a 'hold': you are paid a below-book price for a low-ROE franchise, but nothing in the numbers argues for aggressive accumulation.
Is FNWD a buy? The one-page verdict, explained →
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $15.0M | $15.1M | $8.38M | $12.1M | $8.09M |
| Diluted EPS | $4.30 | $3.60 | $1.96 | $2.84 | $1.88 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Other-events 8-K with exhibits; no earnings or governance change disclosed
Amends prior 8-K to add/correct exhibit; no new substantive news
Annual-meeting voting results reported (directors, auditor ratified)
Q1 2026 10-Q; first quarter after BSA consent order was lifted
Q1 FY2026 earnings released via press-release exhibit
Annual proxy: director slate, auditor and say-on-pay up for vote
FY25 net income -33% to $8.1M, ROE 5.1%; BSA consent order terminated Aug'25
Other-events disclosure with exhibits; routine corporate update
Officer/director change (Item 5.02) plus other-events disclosure
Sources: SEC EDGAR (CIK 0000919864, latest 10-Q filed 2026-05-13) · EODHD · Proprietary analysis · as of 7/3/2026, 3:57:37 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 11:57 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 6 open-market buys · 0 sales
| 2026-06-30 | Johnson Robert E. III Director | Buy | 5.45 @ $35.75 | $194.94 |
| 2026-06-30 | Lowry Robert T Executive Vice President | Buy | 50.64 @ $36.00 | $1.82K |
| 2026-06-30 | Han Amy Wong Director | Buy | 3.59 @ $35.75 | $128.46 |
| 2026-06-30 | Scheub Todd M. Executive Vice President | Buy | 38.96 @ $36.00 | $1.40K |
| 2026-06-30 | Puntillo Anthony Director | Buy | 6.52 @ $35.75 | $233.10 |
| 2026-06-30 | Bochnowski Benjamin J President, CEO | Buy | 6.21 @ $36.00 | $223.44 |
| 2026-05-22 | Johnson Robert E. III Director | Award | 372.00 @ $32.24 | $12.0K |
| 2026-05-22 | Evans Jennifer Director | Award | 372.00 @ $32.24 | $12.0K |
| 2026-05-22 | Han Amy Wong Director | Award | 372.00 @ $32.24 | $12.0K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median